scispace - formally typeset
Y

Yi Liu

Researcher at Beijing University of Chinese Medicine

Publications -  20
Citations -  562

Yi Liu is an academic researcher from Beijing University of Chinese Medicine. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 7, co-authored 10 publications receiving 305 citations. Previous affiliations of Yi Liu include Tianjin University of Traditional Chinese Medicine & Peking University.

Papers
More filters
Journal ArticleDOI

Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics

TL;DR: A comprehensive summary of the pharmacology, toxicity, and pharmacokinetics of aloe‐emodin reported to date is provided with an emphasis on its biological properties and mechanisms of action.
Journal ArticleDOI

Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways

TL;DR: It is concluded that itraconazole exerts anti-liver cancer effect, and has potential for use as a new drug for liver cancer in clinic.
Journal ArticleDOI

Matrine Exerts Hepatotoxic Effects via the ROS-Dependent Mitochondrial Apoptosis Pathway and Inhibition of Nrf2-Mediated Antioxidant Response.

TL;DR: The results show that the hepatotoxic effect of matrine is exerted via inhibition of Nrf2 pathway, activation of ROS-mediated mitochondrial apoptosis pathway, and cell cycle arrest at S phase.
Journal ArticleDOI

Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges

TL;DR: This study was aimed at reviewing the status of research on liver injury due to PM, including clinical characteristics, risk factors, material basis research and mechanism of action, with a view to understanding PM-induced hepatotoxicity, and taking reasonable and effective measures to prevent it.
Journal ArticleDOI

A Novel Gel-Forming Solution Based on PEG-DSPE/Solutol HS 15 Mixed Micelles and Gellan Gum for Ophthalmic Delivery of Curcumin

TL;DR: The ex vivo penetration study revealed that Cur-MMs could penetrate the rabbit cornea more efficiently than the free curcumin and biocompatible Cur-MM-ISG has great potential in ophthalmic drug therapy.